The United States Pharmacopeia Convention (USP) and the United States Food and Drug Administration (FDA) have updated an educational resource on biosimilars to help healthcare practitioners improve patient confidence in the quality and effectiveness of these treatment options. The following are recommended social media, website, and email content you can use to share this resource with your network.
AMCP Signs Joint Stakeholder Letter to the HHS OIG on Safe Harbor for Value-Based Contracts
We, the undersigned organizations, appreciate the opportunity to provide input on modifying and/or establishing safe harbor provisions under the Federal Anti-Kickback Statute. During the past decade, payment models for the delivery of health care have undergone a shift from focusing on volume to focusing on value.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.